Skip to main content
VALIRX PLC logo

VALIRX PLC — Investor Relations & Filings

Ticker · VAL ISIN · GB00BLH13C52 LEI · 213800VQKB9SJCQDET40 IL Professional, scientific and technical activities
Open in API
Filings indexed 574 across all filing types
Latest filing 2014-12-04 Regulatory Filings
Country GB United Kingdom
Listing IL VAL

About VALIRX PLC

https://www.valirx.com/

ValiRx PLC is a life science company that accelerates the development of therapeutics and diagnostics, with a primary focus on oncology and women's health. The company's business model centers on identifying and progressing promising early-stage scientific discoveries through pre-clinical and clinical development. ValiRx provides scientific, financial, and commercial expertise to translate novel research into clinically validated treatments, aiming to improve patient outcomes in its target therapeutic areas.

Recent filings

Filing Released Lang Actions
ValiSeek Scientific Update
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and a date, indicating it is a regulatory announcement from the London Stock Exchange's news service. The content describes a 'ValiSeek Scientific Update' regarding positive safety and toxicology reports for a drug candidate (VAL401) and mentions that these data will support the approach to regulatory authorities for clinical trials. This is a specific operational update concerning scientific progress, not a full financial report (10-K, IR), a management change (MANG), or a dividend announcement (DIV). Since it is a formal, non-financial regulatory announcement that doesn't fit the highly specific categories like DIRS, DVA, or CAP, the most appropriate general regulatory category is RNS (Regulatory Filings), which serves as the fallback for miscellaneous regulatory announcements.
2014-12-04 English
Re: Progress with Trial Recruitment and Testing
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and is dated 26 November 2014. It announces progress on a clinical trial ('Approved Clinical Trial of VAL201') and provides updates on recruitment and expected results. This type of announcement, which conveys material, non-public information to the market via an official channel (RNS), fits best under the general regulatory announcement category. Since it is not a full financial report (10-K, IR), a specific management change (MANG), a dividend notice (DIV), or a director's dealing (DIRS), the most appropriate classification is Regulatory Filings (RNS), which serves as the general category for official regulatory news service releases that don't fit elsewhere. The document length is short (3239 chars), but it is providing substantive news rather than just announcing the publication of another document, making RNS more suitable than RPA.
2014-11-26 English
Collaboration Agreement
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and is dated 13 November 2014. The content announces a 'Collaboration agreement' between ValiRx Plc and the German Cancer Research Center (DKFZ). This type of announcement, detailing a significant business development or agreement, is typically disseminated via regulatory news services. Since it is not a full financial report (10-K, IR), an earnings release (ER), or a specific shareholder vote result (DVA), and it is a formal announcement published through the RNS system, the most appropriate classification is Regulatory Filings (RNS), which serves as a general category for such official, non-standardized announcements. Although it announces a business event, it is not a M&A activity (TAR) or a Capital/Financing Update (CAP). It is a general corporate update disseminated via the RNS system.
2014-11-13 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is clearly identified by the header 'RNS Number : 4586W' and contains the standard structure of a TR-1 notification, which reports changes in major shareholdings. The content details the 'acquisition or disposal of voting rights' by 'YA Global Master SPV, Ltd' and reports the resulting percentage of voting rights (0.7%). This type of mandatory disclosure regarding significant changes in ownership thresholds falls under the category of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2014-11-07 English
Approved Clinical Trial Update
Regulatory Filings Classification · 1% confidence The document is very short (3370 characters) and begins with an RNS Number (9741V) and a date, indicating it is a regulatory announcement rather than a full report. The content announces that 'full details of the VAL201 trial are available on the United States of America's National Institutes of Health searchable database' as a 'legal requirement'. This structure—announcing the availability of detailed information elsewhere—fits the definition of a Report Publication Announcement (RPA). While it is a regulatory filing (RNS), RPA is more specific for announcements about the publication of other documents/details. Given the explicit mention of fulfilling a requirement to post details elsewhere, RPA is the most precise classification, although RNS is also plausible as a fallback.
2014-11-03 English
Total Voting Rights
Regulatory Filings Classification · 1% confidence The document is identified by the 'RNS Number' header and explicitly states, 'This information is provided by RNS The company news service from the London Stock Exchange'. The content announces the 'Total Voting Rights' (2,941,382,514 ordinary shares), which is a mandatory disclosure under the FCA's Disclosure and Transparency Rules. This type of general regulatory announcement that doesn't fit a more specific category (like DIRS, DIV, or SHA) is best classified as a general Regulatory Filing, or RNS, as indicated by the source identifier.
2014-10-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.